+91-8668442535
Home / Biotechnology / Anatomic P

Anatomic Pathology Market By Product (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery And Development) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

This report on the global anatomic pathology market studies various products and applications prevalent in the market. According to the Centers for Disease Control and Prevention, the budget for chronic disease prevention and health promotion for the financial year 2017 is US$1.1 billion, which is self-explanatory regarding the involvement of health regulatory authorities’ drive to promote health and awareness throughout the globe.

The drivers of the anatomic pathology market are the rising prevalence of critical illness, increasing inclination toward a healthier lifestyle, rising demand for personalized medication, and supportive reimbursement scenarios.For the purpose of this study, various products of anatomic pathology examined include instruments, consumables, and services. The instruments segment is further categorized into tissue processing systems, slides staining systems, microtomes, and others; the consumables are sub-segmented as reagents and kits, antibodies, and probes, whereas the services segment includes cytopathology, histopathology, and others.

The application segment comprises disease diagnosis, drug discovery and development, and others. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.The global anatomic pathology market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets.

To further elucidate, the major geographical markets are segmented into country-specific markets as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • AsiaPacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

The regions are also further sub-segmented on the basis of a cross-sectional study by product, application, and major countries. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global anatomic pathology market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study.

Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global anatomic pathology market. The key players profiled in this report are Abbott Laboratories, Inc., Agilent Technologies, Inc., Boston Scientific Corporation, Danaher Corporation, F.Hoffman La Roche AG, Laboratory Corporation of America Holdings, Neogenomics Laboratories, Inc., Quest Diagnostics Incorporated, Sakura Fine technical Co., Ltd., and Thermo Fisher Scientific, Inc.

 The anatomic pathology market is driven by factors such as the rising prevalence of chronic diseases, an aging population, increasing demand for superior medical care, and mergers and acquisitions among healthcare and insurance companies. In 2016, the services segment held the largest revenue share in the market, chiefly due to factors such as the rising prevalence of critical illnesses requiring immediate medical attention. According to the 2002 World Health Report, chronic diseases will account for 73% of all deaths and 60% of the global disease burden by 2020; an aging population and technological advancements in diagnostic techniques will thus propel the services market.

Instruments will be the fastest-growing market throughout the forecast period of 2017–2025 due to drivers such as technological advancement in design and software, the emergence of higher resolution real-time imaging for diagnosis, and highly reliable and accurate interpretation of the diagnosis performed. The major players in providing products and services for the anatomic pathology market are Agilent Technologies, Thermo Fisher Scientific, Inc., Sakura Fine technical Co., Ltd., F. Hoffmann-La Roche AG, and NeoGenomics Laboratories, Inc.

Based on application areas, the global anatomic pathology market is categorized into:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic pathology finds huge application scope because of its utility, which helps patients survive critical diseases through knowledge input from sophisticated tools like pharmacogenomics and new genome sequencing, etc. The increase in government grants for biomedical R&D, growth in the patient pool, and technological advancement in diagnostic devices have all fueled the anatomic pathology application market. Lack of skilled labor and the risk of inaccurate interpretation are the restraints on the anatomic pathology market.

In 2016, disease diagnosis held the largest market share among all the application areas due to the rise in chronic diseases and cancer, the aging population, and an increasing inclination toward a healthier lifestyle. Drug discovery and development will be the fastest-growing segment throughout the forecast period of 2017–2025 due to factors such as enhanced expenditure by government and non-government organizations in R&D initiatives for the introduction of novel and further efficacious drugs, rising demand for personalized medication, and mergers and acquisitions in the healthcare industry to fortify their product portfolio.

Based on products, the global anatomic pathology market is categorized into:

Instruments

  • Tissue processing systems
  • Slides staining systems
  • Microtomes
  • Others

Consumables

  • Reagents and kits
  • Antibodies
  • Probes

Services

  • Cytopathology
  • Histopathology
  • Others

The anatomic pathology market is driven by factors such as the rising prevalence of chronic diseases, an aging population, increasing demand for superior medical care, and mergers and acquisitions among healthcare and insurance companies. In 2016, the services segment held the largest revenue share in the market, chiefly due to factors such as the rising prevalence of critical illnesses requiring immediate medical attention. According to the 2002 World Health Report, chronic diseases will account for 73% of all deaths and 60% of the global disease burden by 2020; an aging population and technological advancements in diagnostic techniques will thus propel the services market. Instruments will be the fastest-growing market throughout the forecast period of 2017–2025 due to drivers such as technological advancement in design and software, the emergence of higher resolution real-time imaging for diagnosis, and highly reliable and accurate interpretation of the diagnosis performed. The major players in providing products and services for the anatomic pathology market are Agilent Technologies, Thermo Fisher Scientific, Inc., Sakura Fine technical Co., Ltd., F. Hoffmann-La Roche AG, and NeoGenomics Laboratories, Inc.

Frequently Asked Questions:

The market for Anatomic Pathology Market is expected to reach US$ 27,265.07 mn By 2025.

The Anatomic Pathology Market is expected to see significant CAGR growth over the coming years, at 5.5%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Abbott Laboratories, Inc., Agilent Technologies, Inc., Boston Scientific Corporation, Danaher Corporation, F.Hoffman La Roche AG, Laboratory Corporation of America Holdings, Neogenomics Laboratories, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Jul 2017
Category:  Biotechnology
Report ID:   58559
Report Format:   PDF
Pages:   120
Rating:    4.7 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support